Previous | Next
Part: 12 Session: 145678910111213141516171819202122 Page 417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465 of 999
of it, and there's been such a block about it that it's really easier to promote the experimental use of it in different forms of cancer than to go on about it in TB.
Curious turn of events.
Isn't that strange?
You said off tape that there hadn't been any new development in the use of BCG for leukemia in children?
Well, I did see one report recently, which is unconformed as far as I know, that the use of BCG plus a drug, a combination of drugs, did not add anything to the remission time. Now, I don't know, this is still as far as I knew not confirmed by any other study, whether it's true or not, but in acute leukenia it did not seem to help, in this one study.
When you went to Dr. Mahler, were you acting on your own or were you acting as an agent of NIH?
No, we were -- my sister had been a friend of Dr. Mahler's Dr. Makler had been head of the TB section of the World Health Organization and then had just become the head of the whole World Health Organization. And we don't seem to have any great difficulty in going to see any doctors, or even in explaining anything about who we are.
Well, I can understand that.
No, I don't really know why, because I don't think that were
© 2006 Columbia University Libraries | Oral History Research Office | Rights and Permissions | Help